ScholarGate
助手

方法对比

并排查看您选择的方法;存在差异的行会高亮显示。

肾脏疾病生活质量量表×EORTC QLQ-C30:癌症生活质量评估的核心问卷×
领域健康结局健康结局
方法族Process / pipelineProcess / pipeline
起源年份19941993
提出者Ron D. Hays et al.Nico Aaronson et al.
类型Self-report quality of life questionnaireSelf-report quality of life questionnaire
开创性文献Hays, R. D., Kallich, J. D., Mapes, D. L., Coons, S. J., & Carter, W. B. (1994). Development of the Kidney Disease Quality of Life (KDQOL) instrument. Quality of Life Research, 3(5), 329-338. DOI ↗Aaronson, N. K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A., Duez, N. J., ... & Takeda, F. (1993). The European Organisation for Research and Treatment of Cancer QLQ-C30: A quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute, 85(5), 365-376. DOI ↗
别名KDQOL, Kidney Disease QoL, KDQOL-SFQLQ-C30, EORTC QLQ-C30, Cancer Quality of Life Scale
相关45
摘要The KDQOL is the most widely used quality of life measure for chronic kidney disease (CKD) patients, particularly those on dialysis. Developed by Ron Hays and colleagues in 1994, this multidimensional questionnaire (full version 134 items; short-form KDQOL-SF 36 items) measures kidney disease-specific impacts on physical function, emotional well-being, social participation, and treatment burden. It is the standard outcome measure in renal research and clinical practice.The EORTC QLQ-C30 is the most widely used international instrument for assessing quality of life in cancer patients. Developed by the European Organisation for Research and Treatment of Cancer in 1993, it measures physical, emotional, cognitive, and social functioning alongside cancer-specific symptoms and financial impact, making it the standard outcome measure in oncology clinical trials and patient care.
ScholarGate数据集
  1. v1
  2. 3 来源
  3. PUBLISHED
  1. v1
  2. 3 来源
  3. PUBLISHED

前往搜索 下载幻灯片

ScholarGate方法对比: KDQOL · EORTC QLQ-C30. 于 2026-06-20 检索自 https://scholargate.app/zh/compare